vancomycin has been researched along with polymyxin b(1) in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 9 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bie, X; Gao, L; Han, J; Liu, H; Lu, Z; Ma, Z; Yang, J; Zhao, H | 1 |
| Dou, X; Feng, X; He, S; Shan, A; Song, J; Wang, J; Yang, Y; Yang, Z | 1 |
| Gou, S; He, Y; Liu, H; Liu, T; Ni, J; Wang, L; Yao, J; Zhang, Y; Zhong, C; Zhu, N; Zhu, Y | 1 |
| Chen, Y; Fan, T; Guo, W; Hu, P; Liu, M; Shao, T; Yi, Z; Zhou, W | 1 |
| Kandi, SK; Kumar, P; Mukhopadhyay, K; Rawat, DS | 1 |
| Gou, S; Ni, J; Xie, J; Yao, J; Zhang, F; Zhong, C; Zhu, N; Zhu, Y | 1 |
| Ba, Z; Chang, L; Gou, S; Li, B; Liu, H; Ni, J; Ouyang, X; Zhang, J; Zhang, T; Zhang, Y; Zhong, C; Zhu, N; Zhu, Y | 1 |
| Choi, W; Efremov, RG; Konshina, AG; Lohan, S; Mandal, D; Maslennikov, I; Parang, K; Tiwari, RK | 1 |
| Lohan, S; Mohammed, EHM; Parang, K; Tiwari, RK | 1 |
| Chen, X; Jiang, Q; Kong, Q; Li, G; Wang, Y; Yu, T; Zhang, F | 1 |
| Akhir, A; Chopra, S; Kaul, G; Meenu, MT; Radhakrishnan, KV; Shukla, M | 1 |
| Aggarwal, B; Bajaj, A; Gupta, S; Gupta, SK; Jain, D; Kumar, S; Kumar, Y; Mehta, D; Pal, G; Pal, S; Rajput, K; Ramu, VS; Rana, K; Rani, P; Saini, V | 1 |
12 other study(ies) available for vancomycin and polymyxin b(1)
| Article | Year |
|---|---|
Insights into the Antimicrobial Activity and Cytotoxicity of Engineered α-Helical Peptide Amphiphiles.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Apoptosis; Bacteria; Cell Cycle; Cell Membrane Permeability; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Peptides; Protein Engineering; Structure-Activity Relationship; Surface-Active Agents | 2016 |
Antimicrobial Peptides with High Proteolytic Resistance for Combating Gram-Negative Bacteria.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Biocompatible Materials; Gram-Negative Bacteria; HEK293 Cells; Humans; Mice; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Proteolysis; RAW 264.7 Cells; Spectrometry, Fluorescence | 2019 |
Design and synthesis of new N-terminal fatty acid modified-antimicrobial peptide analogues with potent in vitro biological activity.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Cell Proliferation; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Drug Design; Fatty Acids; Gram-Negative Bacteria; Gram-Positive Bacteria; Mice; Microbial Sensitivity Tests; Molecular Structure; RAW 264.7 Cells; Structure-Activity Relationship | 2019 |
Design, synthesis and evaluation of phenylthiazole and phenylthiophene pyrimidindiamine derivatives targeting the bacterial membrane.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Cell Membrane; Drug Design; Escherichia coli; Hemolysis; Male; Mice, Inbred C57BL; Microbial Sensitivity Tests; Molecular Structure; Pyrimidines; Rabbits; Staphylococcus aureus; Structure-Activity Relationship; Thiazoles; Thiophenes | 2020 |
Synthesis of novel monocarbonyl curcuminoids, evaluation of their efficacy against MRSA, including ex vivo infection model and their mechanistic studies.
Topics: 3T3 Cells; Animals; Anti-Bacterial Agents; Chemistry Techniques, Synthetic; Diarylheptanoids; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Viability | 2020 |
Ultra-short lipopeptides against gram-positive bacteria while alleviating antimicrobial resistance.
Topics: Animals; Anti-Bacterial Agents; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Female; Gram-Positive Bacteria; Lipopeptides; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2021 |
Novel Broad-Spectrum Antimicrobial Peptide Derived from Anoplin and Its Activity on Bacterial Pneumonia in Mice.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Antineoplastic Agents; Cell Line; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Structure; Pneumonia, Bacterial; Pore Forming Cytotoxic Proteins; Structure-Activity Relationship; Wasp Venoms | 2021 |
Small Amphiphilic Peptides: Activity Against a Broad Range of Drug-Resistant Bacteria and Structural Insight into Membranolytic Properties.
Topics: Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Bacteria; Cell Membrane; Cell Survival; Drug Design; Gram-Negative Bacteria; Gram-Positive Bacteria; HEK293 Cells; Hemolysis; Humans; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Molecular Dynamics Simulation; Peptides | 2022 |
Amphiphilic cyclic peptide [W
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Gram-Negative Bacteria; Gram-Positive Bacteria; Meropenem; Microbial Sensitivity Tests; Peptides, Cyclic; Pseudomonas aeruginosa | 2022 |
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Biofilms; Biomimetics; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests | 2022 |
Developing the Natural Prenylflavone Artocarpin from
Topics: Animals; Anti-Bacterial Agents; Artocarpus; Biofilms; Flavonoids; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus | 2022 |
Targeting Vancomycin-Resistant
Topics: Anti-Bacterial Agents; Cholic Acid; Drug Resistance, Bacterial; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Operon; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2022 |